Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital

Chest

Volumn 105, Issue 4, 1994, Pages 997-1002

  Stomel, R J ^a   Rasak, M ^a   Bates, E R ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; DOPAMINE; NORADRENALIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; AORTA BALLOON; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CLINICAL TRIAL; FEMALE; HEART INFARCTION; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL;

EID: 0028214880     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.105.4.997     Document Type: Article

References (24)

1. JR Goldberg MJ Gore SJ Alpert V Osganin J Groot B Jergen Cardiogenic shock after acute myocardial infarction? N Engl J Med 325 1991 1117 1122
2. LA Kuhn The treatment of cardiogenic shock: I. The nature of cardiogenic shock? Am Heart J 74 1967 578 581
3. Gruppo Italiano per lo Studeo Della Streptochinasi Nell'infarto Miocardico (GISSI) Effectiveness of intravenous thrombolytic treatment of acute myocardial infarction? Lancet 1 1986 397 401
4. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS 2? Lancet 2 1988 349 360
5. L Lee E Bates B Pitt JA Walton N Laufer WW O'Neill Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock? Circulation 78 1988 1345 1351
6. ER Bates EJ Topol Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock? J Am Coll Cardiol 18 1991 1077 1084
7. Product information Activase (Alteplase, recombinant) 1988 Genentech Inc South San Francisco, Calif
8. Product information Kabikinase (streptokinase) 1989 KabiVitrum AB Stockholm, Sweden
9. S Scheidt R Ashem T Killip Shock after acute myocardial infarction: a clinical and hemodynamic profile? Am J Cardiol 26 1970 556 564
10. M Malach BA Rosenberg Acute myocardial infarction in a city hospital experience with cardiogenic shock? Am J Cardiol 5 1960 487 492
11. N Kelman M Terrin H Mueller B Chaitman R Roberts G Knattend Mechanisms of early death despite thrombolytic therapy: experience from the thrombolysis in myocardial infarction, phase II (TIMI II) study? J Am Coll Cardiol 19 1992 1129 1135
12. AIMS Trial Study Group Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial? Lancet 1 1988 545 549
13. RG Wilcox G von der Lippe CG Olsson G Jensen AM Skene JR Hampton Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction? Lancet 2 1988 525 530
14. S Yusuf R Collins R Peto C Furberg MJ Stampfer SZ Goldhaber Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction, and side-effects from 33 randomized control trials? Eur Heart J 6 1985 556 585
15. F Hagemeijer JD Laird MP Haalabes PG Hugenholtz Effectiveness of intra-aortic balloon pumping without cardiac surgery for patients with severe heart failure secondary to recent myocardial infarction? Am J Cardiol 40 1977 951 956
16. S Scheidt G Wilner H Mueller D Summers M Lesch G Wolff Intra-aortic balloon pump counterpulsation in cardiogenic shock: report of a cooperative clinical trial? N Engl J Med 288 1973 979 984
17. M Goldberg SW Tabak SK Prediman Clinical experience with intra-aortic balloon pump counterpulsation in 112 consecutive patients? Am Heart J 111 1986 497 502
18. JR Bengston AJ Kaplan KS Pieper NM Wildermann DB Mark DB Pryor Prognosis in cardiogenic shock after acute myocardial infarction in interventional era? J Am Coll Cardiol 20 1992 1482 1489
19. Ohman EM, Califf RM, George BS, Quigley PJ, Kereiakes DJ, Woodlief LH, et al. The use of intra-aortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J 121:895-901
20. M Funk J Gleason O Foell Lower limb ischemia related to use of the intraaortic balloon pump? Heart Lung 18 1989 542 552
21. PX Adams D Bregman Peripheral vascular problems in patients requiring intra-aortic balloon counterpulsation Cardiac Surg State Art Rev. 2 1987 99 107
22. M Goldberg NS Tabak PK Shah Clinical experience with intra-aortic balloon counterpulsation in 112 consecutive patients? Am Heart J 111 1986 497 502
23. M Goodwin J Hartmann L Mikeever Safety of intraaortic balloon counterpulsation in patients with acute myocardial infarction receiving streptokinase intravenously? Am J Cardiol 64 1989 937 938
24. AJ Silverman AM Williams WR Wetmore RJ Stomel Complications of intra-aortic balloon pump counterpulsation in patients receiving thrombolytic therapy for acute myocardial infarction? J Intervent Cardiol 4 1991 49 52